See section 1.4 for general contraindications for all vaccines.
Monovalent VV and MMRV vaccine are contraindicated for the following people:
individuals with primary or acquired T-cell immune deﬁciency states – consult the child’s paediatrician for advice24
children on high-dose steroids for more than two weeks (ie, children on 2 mg/kg per day or more of prednisone or its equivalent, or 20 mg per day if their weight is over 10 kg)
individuals with known systemic hypersensitivity to neomycin
individuals with active untreated tuberculosis
women during pregnancy – women should be advised to avoid pregnancy for four weeks after vaccination24 (the vaccine’s safety for the fetus has not yet been demonstrated, although no congenital defects have been described following inadvertent administration to pregnant women; a pregnant mother is not a contraindication for immunisation of a child in the household and the vaccine can be administered to non-immune mothers who are breastfeeding).
There is also a relative contraindication for children on salicylates: because of the association between Reye syndrome, natural varicella infection and salicylates, the vaccine manufacturers advise against the use of salicylates for six weeks after varicella vaccine is given. There has been no reported association between the vaccine and Reye syndrome, but avoidance of salicylates is recommended as a precaution,24 and physicians need to weigh the theoretical risk of Reye syndrome from the vaccine against the known risk from varicella disease in children receiving long-term salicylate therapy.